#Global

This year’s theme is “Communities Make the Difference.”

Hepatitis B and C, non-alcoholic steatohepatitis (NASH) and alcohol-related liver disease are the main causes of liver cancer and cirrhosis.

Women with a history of the malignancy also survive longer than men after receiving a liver transplant.

It’s time, leaders say, to decentralize hepatitis C care from urban areas and get nonspecialists to provide care.

Nevertheless, researchers are hoping to learn more from the study of the caspase inhibitor among people with non-alcoholic steatohepatitis.

This finding concerns liver cancer diagnosed after being cured of hepatitis C.

Researchers analyzed cancer outcomes among a large group of South Koreans with hepatitis B virus.

Events are scheduled throughout September to raise awareness about hep B and HIV in these communities.

This is according to an analysis of nearly 5,000 Italians recently treated for the virus.

Researchers analyzed the association between heavy drinking and immune function in those with untreated HIV.

A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.

Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.

Australia has led the world in an aggressive push to provide its citizens with low-cost treatment for the virus.

Help find the “missing millions” who don’t know they’re living with viral hepatitis.

An analysis conducted in Taiwan analyzed health outcomes over more than a decade.

Researchers found that this association was statistically significant beginning five years after treatment.